It was found that β-caryophyllene oxide decreased the constitutive STAT3 activation in multiple myeloma, prostate, and breast cancer cells, and has a critical concentration- and time-dependent response in multiple myeloma cells. Here, STAT3 is linked to breast carcinoma.